secwatch.observer — SEC 8-K summary
======================================

Issuer:     PetVivo Holdings, Inc. (PETV)
CIK:        0001512922
Form:       8-K
Filed at:   2024-09-26T23:59:59+00:00
Accession:  0001493152-24-038223
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PetVivo appoints Mike Eldred to board, expanding from seven to eight directors
------------------------------------------------------------------------------

- Board increased to eight directors, effective Sep 25, 2024; Eldred fills new seat.
- Eldred served as president/CEO of Dechra Pharmaceutical's North American ops until June 2024.
- At Dechra he built team to 250+ people and grew sales to £191.6 million.
- Eldred is deemed independent under Exchange Act; no committee assignment yet.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512922/000149315224038223/0001493152-24-038223-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512922/000149315224038223/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-038223

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer